Otolaryngology Doctors in Warwick, RI Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

Robert Michael Risica, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800    Fax: 401-921-5826

Dr. Charles Sidney Faber, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800

Dr. Alejandro Vazquez, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800    Fax: 401-921-5826

Dr. Mark Peter Andreozzi, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800    Fax: 401-921-5826

Dr. Amit Patel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800    Fax: 401-921-5826

George J. Jacewicz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 95 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-6111    Fax: 401-732-0155

Dr. Barbara Jean Guillette, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3520 Post Rd, Warwick, RI 02886 Phone: 401-921-5800    Fax: 401-921-5826

News Archive

Nominations open for first annual Most Influential in Specialty Health Award

The National Association of Specialty Health Organizations today announced that nominations are being accepted for the first annual Most Influential in Specialty Health Award. This award will recognize leaders in specialty health who have played a major role in advancing the industry's mission to improve value, access and availability of high quality specialty health services.

Toremifene reduces fracture risk in men with prostate cancer after initiation of androgen deprivation therapy

GTx, Inc. today announced that additional study results from the Phase III clinical trial evaluating toremifene 80 mg for the prevention of fractures in men with prostate cancer on androgen deprivation therapy will be presented at the 2010 Annual Meeting of the American Urological Association being held in San Francisco May 29-June 3.

HDC, NeoGenomics sign worldwide licensing agreement to develop LDT

Health Discovery Corporation, a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licensing agreement with NeoGenomics, Inc. for laboratory developed tests in the Field of hematopoietic and solid tumor cancers excluding breast cancer, which was previously licensed to Quest Diagnostics and Smart Personalized Medicine and excluding cancer of the retina which was previously committed to Retinalyze, LLC.

Synthetic nanoparticle can light up and treat atherosclerotic plaques

Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body and wreak havoc. Scientists have now developed a nanoparticle that functionally mimics nature's own high-density lipoprotein (HDL). The nanoparticle can simultaneously light up and treat atherosclerotic plaques that clog arteries. Therapy with this approach could someday help prevent deadly heart attacks and strokes.

Read more Medical News

› Verified 7 days ago